Peripheral urocortin delays gastric emptying: Role of CRF receptor 2

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 276, Issue 4 39-4, 1999, Pages

  Nozu, Tsukasa ^a   Martinez, Vicente ^a,c   Rivier, Jean ^b   Taché, Yvette ^a,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c Departamento de Derecho Penal Edificio Seminario   (Spain)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Abdominal surgery; Antalarmin; Astressin; Corticotropin releasing factor; NBI 27914; Postoperative gastric ileus

Indexed keywords

5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2,4,6 TRICHLOROANILINO)PYRIMIDINE; ANTALARMIN; ASTRESSIN; CORTICOTROPIN RELEASING FACTOR; UNCLASSIFIED DRUG; UROCORTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; HORMONE RELEASE; LIGAND BINDING; MAMMAL; NONHUMAN; PARALYTIC ILEUS; PRIORITY JOURNAL; RECEPTOR BINDING; STOMACH EMPTYING;

EID: 0032906505     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.276.4.g867     Document Type: Article

References (56)

1. Bamberger, C. M., M. Wald, A. M. Bamberger, S. Ergun, F. U. Beil, and H. M. Schulte. Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J. Clin. Endocrinol. Metab. 83: 708-711, 1998.
2. Banks, W. A., and A. J. Kastin. Passage of peptides across the blood-brain barrier: pathophysiological perspectives. Life Sci. 59: 1923-1943, 1996.
3. Barquist, E., B. Bonaz, V. Martinez, J. Rivier, M. J. Zinner, and Y. Taché. Neuronal pathways involved in abdominal surgery-induced gastric ileus in rats. Am. J. Physiol. 270 (Regulatory Integrative Comp. Physiol. 39): R888-R894, 1996.
4. Barquist, E., M. Zinner, J. Rivier, and Y. Taché. Abdominal surgery-induced delayed gastric emptying in rats: role of CRF and sensory neurons. Am. J. Physiol. 262 (Gastrointest. Liver Physiol. 25): G616-G620, 1992.
5. Broccardo, M., and G. Improta. Pituitary-adrenal and vagus modulation of sauvagine- and CRF-induced inhibition of gastric emptying in rats. Eur. J. Pharmacol. 182: 357-362, 1990.
6. Chalmers, D. T., T. W. Lovenberg, D. E. Grigoriadis, D. P. Behan, and E. B. De Souza. Corticotropin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 17: 166-172, 1996.
7. Chen, C., Jr., R. Dagnino, E. B. De Souza, D. E. Grigoriadis, C. Q. Huang, K. K. I. Kim, Z. Liu, T. Moran, T. R. Webb, J. P. Whitten, Y. F. Xie, and J. R. McCarthy. Design and synthesis of a series of non-peptide high affinity human corticotropin-releasing factor receptor antagonists. J. Med. Chem. 39: 4358-4360, 1996.
8. Chen, Y. L., R. S. Mansbach, S. M. Winter, E. Brooks, J. Collins, M. L. Corman, A. R. Dunaiskis, W. S. Faraci, R. J. Gallaschun, A. Schmidt, and D. W. Schulz. Synthesis and oral efficacy of a 4-(butylethylamino)pyrrolo[2,3-d]pyrimidine: a centrally active corticotropin-releasing factor1 receptor antagonist. J. Med. Chem. 40: 1749-1754, 1997.
9. Coskun, T., A. Bozkurt, I. Alican, U. Özkutlu, H. Kurtel, and Ç. Yegen. Pathways mediating CRF-induced inhibition of gastric emptying in rats. Regul. Pept. 69: 113-120, 1997.
10. Donaldson, C. J., S. W. Sutton, M. H. Perrin, A. Z. Corrigan, K. A. Lewis, J. E. Rivier, J. M. Vaughan, and W. W. Vale. Cloning and characterization of human urocortin. Endocrinology 137: 2167-2170, 1996.
11. 9-41 in three bioassay systems. Endocrinology 129: 1312-1316, 1991.
12. Gulyas, J., C. Rivier, M. Perrin, S. C. Koerber, S. Sutton, A. Corrigan, S. L. Lahrichi, A. G. Graig, W. Vale, and J. Rivier. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc. Natl. Acad. Sci. USA 92: 10575-10579, 1995.
13. Heinrichs, S. C., F. Menzaghi, P. E. Merlo, K. T. Britton, and G. F. Koob. The role of CRF in behavioral aspects of stress. Ann. NY Acad. Sci. 771: 92-104, 1995.
14. Imeryuz, N., B. C. Yegen, A. Bozkurt, T. Coskun, M. L. Villanueva-Penacarrillo, and N. B. Ulusoy. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am. J. Physiol. 273 (Gastrointest. Liver Physiol. 36): G920-G927, 1997.
15. Improta, G. Evolutionary aspects of peripheral peptidergic signals: CRF-like peptides and modulation of G. I. functions. In: Sensory Nerves and Neuropeptides in Gastroenterology, edited by M. Costa. New York: Plenum, 1991, p. 75-83.
16. Karalis, K., H. Sano, J. Redwine, S. Listwak, R. L. Wilder, and G. P. Chrousos. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254: 421-423, 1991.
17. Kishimoto, T., R. V. Pearse, C. R. Lin, and M. G. Rosenfeld. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 92: 1108-1112, 1995.
18. Kostich, W. A., A. Chen, K. Sperle, and B. L. Largent. Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2y receptor. Mol. Endocrinol. 12: 1077-1085, 1998.
19. Lederis, K., A. Letter, D. McMaster, G. Moore, and D. Schlesinger. Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus. Science 218: 162-165, 1982.
20. Lenz, H. J., M. Burlage, A. Raedler, and H. Greten. Central nervous system effects of corticotropin-releasing factor on gastrointestinal transit in the rat. Gastroenterology 94: 598-602, 1988.
21. Lenz, H. J., A. Raedler, H. Greten, W. W. Vale, and J. E. Rivier. Stress-induced gastrointestinal secretory and motor responses in rats are mediated by endogenous corticotropin-releasing factor. Gastroenterology 95: 1510-1517, 1988.
22. Liaw, C. W., D. E. Grigoriadis, M. T. Lorang, S. E. De, and R. A. Maki. Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors. Mol. Endocrinol. 11: 2048-2053, 1997.
23. Lovenberg, T. W., D. T. Chalmers, C. Liu, and E. B. De Souza. CRF2α and CRF2β receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology 136: 4139-4142, 1995.
24. Lovenberg, T. W., C. W. Liaw, D. E. Grigoriadis, W. Clevenger, D. T. Chalmers, E. B. De Souza, and T. Oltersdorf. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA 92: 836-840, 1995.
25. 2 receptors. Am. J. Physiol. 274 (Gastrointest. Liver Physiol. 37): G965-G970, 1998.
26. Martinez, V., J. Rivier, and Y. Taché. Peripheral actions of the new CRF antagonist, astressin in rats. Gastroenterology 112: 4358-4360, 1997.
27. Martinez, V., J. Rivier, L. Wang, and Y. Taché. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function. J. Pharmacol. Exp. Ther. 280: 754-760, 1997.
28. Martins, J. M., W. A. Banks, and A. J. Kastin. Acute modulation of active carrier-mediated brain-to-blood transport of corticotropin-releasing hormone. Am. J. Physiol. 272 (Endocrinol. Metab. 35): E312-E319, 1997.
29. Martins, J. M., W. A. Banks, and A. J. Kastin. Transport of CRH from mouse brain directly affects peripheral production of beta-endorphin by the spleen. Am. J. Physiol. 273 (Endocrinol. Metab. 36): E1083-E1089, 1997.
30. McInturf, S. M., and M. B. Hennessy. Peripheral administration of a corticotropin-releasing factor antagonist increases the vocalizing and locomotor activity of isolated guinea pig pups. Physiol. Behav. 60: 707-710, 1996.
31. Morcor, J. G., C. B. Lawrence, and P. A. Copeland. Corticotropin-releasing factor binding sites undergo axonal transport in the rat vagus nerve. J. Neuroendocrinol. 4: 281-285, 1992.
32. Naito, Y., J. Fukata, S. Tamai, N. Seo, Y. Nakai, K. Mori, and H. Imura. Biphasic changes in hypothalamo-pituitary-adrenal function during the early recovery period after major abdominal surgery. J. Clin. Invest. 73: 111-117, 1991.
33. Owens, M. J., and C. B. Nemeroff. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43: 425-473, 1991.
34. Pappas, T., H. Debas, and Y. Taché. Corticotropin-releasing factor inhibits gastric emptying in dogs. Regul. Pept. 11: 193-199, 1985.
35. Pappas, T. N., H. T. Debas, A. M. Chang, and I. L. Taylor. Peptide YY release by fatty acids is sufficient to inhibit gastric emptying in dogs. Gastroenterology 91: 1386-1389, 1986.
36. Perrin, M., C. Donaldson, R. Chen, A. Blount, T. Berggren, L. Bilezikjian, P. Sawchenko, and W. Vale. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. USA 92: 2969-2973, 1995.
37. Perrin, M. H., S. W. Sutton, L. A. Cervini, J. E. Rivier, and W. W. Vale. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of CRF receptors. J. Pharmacol. Exp. Ther. 288: 729-734, 1999.
38. Raybould, H. E., C. B. Koelbel, E. A. Mayer, and Y. Taché. Inhibition of gastric motor function by circulating corticotropin-releasing factor in anesthetized rats. J. Gastrointest. Motil. 2: 265-272, 1990.
39. Raybould, H. E., and Y. Taché. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathways in rats. Am. J. Physiol. 255 (Gastrointest. Liver Physiol. 18): G242-G246, 1988.
40. Rivier, C., J. Rivier, and S. Lee. Importance of pituitary and brain receptors for corticotrophin-releasing factor in modulating alcohol-induced ACTH secretion in the rat. Brain Res. 721: 83-90, 1996.
41. Riviere, P. J., X. Pascaud, E. Chevalier, and J. L. Junien. Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents. J. Pharmacol. Exp. Ther. 270: 846-850, 1994.
42. Rohde, E., J. Furkert, K. Fechner, M. Beyermann, M. J. Mulvany, R. M. Richter, C. Denef, M. Bienert, and H. Berger. Corticotropin-releasing hormone (CRH) receptors in the mesenteric small arteries of rats resemble the (2)-subtype. Biochem. Pharmacol. 52: 829-833, 1996.
43. 2 receptors: membrane homogenate and autoradiographic studies. J. Pharmacol. Exp. Ther. 286: 459-468, 1998.
44. Schafer, M., S. A. Mousa, Q. Zhang, L. Carter, and C. Stein. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc. Natl. Acad. Sci. USA 93: 6096-6100, 1996.
45. Sheldon, R. J., J. A. Qi, F. Porreca, and L. A. Fisher. Gastrointestinal motor effects of corticotropin-releasing factor in mice. Regul. Pept. 28: 137-151, 1990.
46. Smith, G. W., J. M. Aubry, F. Dellu, A. Contarino, L. M. Bilezikjian, L. H. Gold, R. Chen, Y. Marchuk, C. Hauser, C. A. Bentley, P. E. Sawchenko, G. F. Koob, W. Vale, and K. F. Lee. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20: 1093-1102, 1998.
47. Sütö, G., Á. Kiraly, V. Plourde, and Y. Taché. Intravenous interleukin-1-beta-induced inhibition of gastric emptying: involvement of central corticotropin-releasing factor and prostaglandin pathways in rats. Digestion 57: 135-140, 1996.
48. Taché, Y., E. Barquist, R. L. Stephens, and J. Rivier. Abdominal surgery- and trephination-induced delay in gastric emptying is prevented by intracisternal injection of CRF antagonist in the rat. J. Gastrointest. Motil. 3: 19-25, 1991.
49. Taché, Y., M. Maeda-Hagiwara, and C. M. Turkelson. Central nervous system action of corticotropin-releasing factor to inhibit gastric emptying in rats. Am. J. Physiol. 253 (Gastrointest. Liver Physiol. 16): G241-G245, 1987.
50. Taché, Y., H. Mönnikes, B. Bonaz, and J. Rivier. Role of CRF in stress-related alterations of gastric and colonic motor function. Ann. NY Acad. Sci. 697: 233-243, 1993.
51. Turnbull, A. V., and C. Rivier. Corticotropin-releasing factor (CRF) and endocrine response to stress: CRF receptors, binding protein, and related peptides. Proc. Soc. Exp. Biol. Med. 215: 1-10, 1997.
52. Turnbull, A. V., W. Vale, and C. Rivier. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur. J. Pharmacol. 303: 213-216, 1996.
53. Vale, W., J. Spiess, C. Rivier, and J. Rivier. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213: 1394-1397, 1981.
54. Vaughan, J., C. Donaldson, J. Bittencourt, M. H. Perrin, K. Lewis, S. Sutton, R. Chan, A. V. Turnbull, D. Lovejoy, C. Rivier, J. Rivier, P. E. Sawchenko, and W. Vale. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378: 287-292, 1996.
55. Webster, E. L., D. B. Lewis, D. J. Torpy, E. K. Zachman, K. C. Rice, and G. P. Chrousos. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology 137: 5747-5750, 1996.
56. Williams, C. L., J. M. Peterson, R. G. Villar, and T. F. Burks. Corticotropin-releasing factor directly mediates colonic responses to stress. Am. J. Physiol. 253 (Gastrointest. Liver Physiol. 16): G582-G586, 1987.